Skip to content

NRIX

Nurix Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$23.00-0.54%

Price as of Jul 20, 2026

NRIX ownership

Nurix Therapeutics, Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$1.7M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +31.8%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 2, 2026Ring Christineofficer: Chief Legal OfficerOption5,221$1.86
Jul 2, 2026Ring Christineofficer: Chief Legal OfficerSell11,008$23.56
Jul 2, 2026Ring Christineofficer: Chief Legal OfficerOption5,787$8.72
Jun 25, 2026Ring Christineofficer: Chief Legal OfficerOption13,333$7.26
Jun 25, 2026Ring Christineofficer: Chief Legal OfficerSell28,935$20.06
Jun 25, 2026Hansen Gwennofficer: Chief Scientific OfficerSell5,394$20.00
Jun 25, 2026Ring Christineofficer: Chief Legal OfficerOption15,602$8.72
Jun 2, 2026Ring Christineofficer: Chief Legal OfficerOption3,422$1.86
Jun 2, 2026Ring Christineofficer: Chief Legal OfficerSell8,148$16.60
May 15, 2026DANSEY ROGER DdirectorGrant31,250$15.86
May 15, 2026Reinsdorf Judith AdirectorGrant31,250$15.86
May 15, 2026Saltzman Edward CdirectorGrant31,250$15.86
May 15, 2026Baynes Roy D.directorGrant31,250$15.86
May 15, 2026Lacey David L.directorGrant31,250$15.86
May 15, 2026GREGORY JULIA PdirectorGrant31,250$15.86
May 15, 2026Kapur AnildirectorGrant31,250$15.86
May 15, 2026Silva Paul MdirectorGrant31,250$15.86
May 5, 2026van Houte Hansofficer: Chief Financial OfficerSell582$17.18
May 5, 2026van Houte Hansofficer: Chief Financial OfficerSell13,473$16.58
May 4, 2026Ring Christineofficer: Chief Legal OfficerSell8,148$16.96
May 1, 2026Ring Christineofficer: Chief Legal OfficerSell5,394$16.76
Apr 30, 2026Hansen Gwennofficer: Chief Scientific OfficerOption2,000
Apr 30, 2026Hansen Gwennofficer: Chief Scientific OfficerOption2,858
Apr 30, 2026Ring Christineofficer: Chief Legal OfficerOption2,000
Apr 30, 2026van Houte Hansofficer: Chief Financial OfficerOption2,000
Apr 30, 2026van Houte Hansofficer: Chief Financial OfficerSell2,388$16.65
Apr 30, 2026Ring Christineofficer: Chief Legal OfficerOption2,858
Apr 30, 2026van Houte Hansofficer: Chief Financial OfficerOption3,750
Apr 30, 2026Ring Christineofficer: Chief Legal OfficerOption3,750
Apr 30, 2026Ring Christineofficer: Chief Legal OfficerSell3,214$16.65

Source: NRIX SEC Form 4 filings, latest Jul 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their NRIX positions over the last 6 months (SEC Form 13F).

Increased
168
New positions
77
Reduced
75
Sold out
57
Largest moves
InstitutionActionSharesFiled
BLACKROCK, INC.Increased8.9MMay 13, 2026
BLACKROCK, INC.Increased8.9MFeb 12, 2026
REDMILE GROUP, LLCIncreased8.1MFeb 17, 2026
REDMILE GROUP, LLCReduced7.7MMay 15, 2026
DEEP TRACK CAPITAL, LPIncreased7.0MFeb 13, 2026
VESTAL POINT CAPITAL, LPIncreased6.5MMay 15, 2026
DEEP TRACK CAPITAL, LPReduced6.3MMay 15, 2026
VANGUARD GROUP INCIncreased5.9MJan 29, 2026
FMR LLCIncreased5.5MMay 15, 2026
STATE STREET CORPIncreased5.1MMay 15, 2026
MORGAN STANLEYReduced4.9MMay 15, 2026
GENERAL ATLANTIC, L.P.New Position4.9MFeb 17, 2026
MORGAN STANLEYIncreased4.9MFeb 13, 2026
VESTAL POINT CAPITAL, LPIncreased4.7MFeb 17, 2026
BAKER BROS. ADVISORS LPUnchanged4.7MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.